Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
105
-
Total shares
-
27.3M
-
Shares change
-
-87.2K
-
Total reported value, excl. options
-
$754M
-
Value change
-
+$21.9M
-
Put/Call ratio
-
1.11
-
Number of buys
-
55
-
Number of sells
-
-52
-
Price
-
$27.62
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q4 2020
111 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q4 2020.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.3M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (5.1M shares), Bellevue Group AG (4.8M shares), WELLINGTON MANAGEMENT GROUP LLP (3.71M shares), LORD, ABBETT & CO. LLC (1.86M shares), VICTORY CAPITAL MANAGEMENT INC (1.71M shares), Cormorant Asset Management, LP (1.7M shares), NORGES BANK (1.53M shares), PFM Health Sciences, LP (1.05M shares), Rock Springs Capital Management LP (515K shares), and Pier Capital, LLC (404K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.